ArticlePloS one2026
LiteFeatNet: A parameter-efficient and performance-centric deep learning model for multi-ocular disease identification using intermediate feature reduction from fundus images.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Knowledge Distillation and Explainability Analysis for Lightweight Retinal Disease Classification Using MultiEYE Fundus Images.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Convolutional Neural Networks (CNNs) require a larger amount of input samples and computing resources to learn discriminative features for accurate identification of multiple retinal conditions, making the development and deployment of such models challenging on limited computing resources. This study presents a robust CNN (called LiteFeatNet) that requires fewer trainable parameters, computational resources, and processing time for accurate prediction. To enhance robustness and reduce computational time, a pre-trained NASNetMobile backbone is employed, and a method for time-efficient discriminative feature extraction from deep intermediate layers is proposed. The extracted features are refined using a spatially-aware feature map reduction module and classified using a custom classification module with fewer number of trainable parameters, reduced computational resource requirements, and computational time. Experiments are conducted using 1824 images from three distinct class labels in the Retinal Fundus Multi-Disease Image Dataset (RFMiD), with a 60:20:20 train-validation-test split. The LiteFeatNet architecture has a compact size (19.87 MB) and was trained using a standard pre-processing pipeline and training configurations. It outperformed twelve state-of-the-art models, achieving the highest testing accuracy of 90.33%, precision of 90.69%, recall of 90.33%, and F1-score of 90.27%, with a fast, impressive inference time of 4 milliseconds per image. Further, a generalizability study was also conducted using an external dataset, RFMiD 2.0, and the LiteFeatNet achieved competitive performance with quicker testing time compared to other architectures. To evaluate the scalability and adaptability of our proposed integrated framework for larger multi-class problems, we assessed the scalability by increasing class label complexity using two additional disease categories. Results validated the effectiveness and computational efficiency of this integrated framework compared with 9 baseline architectures. An ablation study was also conducted using the LiteFeatNet and two top-performing transfer learning architectures to validate that the synergistic combination of deep feature extraction and feature map refinement is the primary design decision behind the success of the LiteFeatNet architecture. The evaluation metrics, thus obtained, strongly suggest that the proposed LiteFeatNet is lightweight, fast, and robust, rendering it suitable for deployment in low-resource clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.